miércoles, 21 de agosto de 2024

Neoadjuvant Immunotherapy Shows Promise for High-Risk HCC Edited by Patricia McKnight August 20, 2024

https://www.medscape.com/viewarticle/neoadjuvant-immunotherapy-shows-promise-high-risk-hcc-2024a1000f81

No hay comentarios:

Publicar un comentario